文献速递前列腺癌

直肠指检不是前列腺癌的有效筛查试验

Digital Rectal Examination Is Not a Useful Screening Test for Prostate Cancer.
PubMed 文献 · Eur Urol Oncol · 2023-10-06

在多中心随机PROBASE试验中,45岁男性单次直肠指检筛查前列腺癌的检出率为0.05%(3/6537),低于PSA筛查的0.21%(48/23301);在PSA筛查驱动的活检中,86%的前列腺癌病例直肠指检结果无异常。作者认为直肠指检不应推荐作为年轻男性的前列腺癌筛查试验。

要点

  • 45岁男性单次直肠指检筛查前列腺癌检出率为0.05%(3/6537),PSA筛查为0.21%(48/23301)。
  • 直肠指检相对PSA筛查的真阳性检出率为0.22(95%CI 0.07-0.72),假阳性检出率为2.2(95%CI 1.50-3.17)。
  • 在PSA筛查检出的前列腺癌中,86%直肠指检结果无异常,敏感性相对PSA为14%。

核心结论

  • 单用直肠指检筛查前列腺癌的性能较差,不应推荐作为年轻男性的前列腺癌筛查试验,且直肠指检不能改善PSA筛查检出的前列腺癌的检出。

研究设计与样本

  • 本分析在多中心随机PROBASE试验内进行,该试验入组超过46000名45岁男性,用于测试风险适配的前列腺特异性抗原(PSA)筛查。
  • 分析一:在试验一个臂的6537名男性中,分析45岁时单次、单用直肠指检作为筛查手段。
  • 分析二:在578例PSA筛查驱动的活检中,评估直肠指检结果。

主要发现

  • 45岁时直肠指检可疑的57名男性中,前瞻性分析发现3例前列腺癌。
  • 直肠指检检出率为0.05%(3/6537),PSA筛查检出率为0.21%(48/23301),后者约为前者的四倍。
  • 直肠指检相对PSA筛查的真阳性检出率为0.22(95%CI 0.07-0.72),假阳性检出率为2.2(95%CI 1.50-3.17)。
  • 在PSA筛查检出的前列腺癌病例中,86%直肠指检结果无异常,相对PSA的敏感性为14%。
  • 这些肿瘤中多数(86%)位于磁共振成像可见的前列腺潜在可触及区域。

关键数值与推荐

  • 直肠指检检出率0.05%(3/6537)vs PSA筛查检出率0.21%(48/23301)。
  • 直肠指检相对PSA筛查的真阳性检出率为0.22(95%CI 0.07-0.72)。
  • 直肠指检相对PSA筛查的假阳性检出率为2.2(95%CI 1.50-3.17)。
  • PSA筛查检出的前列腺癌中,86%直肠指检无异常,相对PSA的敏感性为14%。

临床怎么用

  • 作者认为,单用直肠指检筛查前列腺癌的性能较差,不应推荐作为年轻男性的前列腺癌筛查试验。
  • 作者认为,直肠指检不能改善PSA筛查检出的前列腺癌的检出。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Annual digital rectal examination (DRE) is recommended as a stand-alone screening test for prostate cancer (PCa) in Germany for 45+ yr olds. DRE diagnostic performance in men as young as 45 yr old has not been proved by a screening trial. OBJECTIVE: To determine DRE diagnostic performance in a screening trial. DESIGN, SETTING, AND PARTICIPANTS: This analysis was conducted within the multicentric, randomized PROBASE trial, which enrolled >46 000 men at age 45 to test risk-adapted prostate-specific antigen (PSA) screening for PCa. INTERVENTION: (1) DRE was analyzed as a one-time, stand-alone screening offer at age 45 in 6537 men in one arm of the trial and (2) PCa detection by DRE was evaluated at the time of PSA-screen-driven biopsies (N = 578). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: (1) True-/false-positive detection rates of DRE as compared with PSA screening and (2) DRE outcome at the time of a prostate biopsy were evaluated. RESULTS AND LIMITATIONS: (1) A prospective analysis of 57 men with suspicious DRE at age 45 revealed three PCa. Detection rate by DRE was 0.05% (three of 6537) as compared with a four-fold higher rate by PSA screening (48 of 23 301, 0.21%). The true-positive detection rate by DRE relative to screening by PSA was 0.22 (95% confidence interval [CI] = [0.07-0.72]) and the false-positive detection rate by DRE was 2.2 (95% CI = [1.50-3.17]). (2) Among PSA-screen-detected PCa cases, 86% had unsuspicious DRE (sensitivity relative to PSA was 14%), with the majority of these tumors (86%) located in the potentially accessible zones of the prostate as seen by magnetic resonance imaging. CONCLUSIONS: The performance of stand-alone DRE to screen for PCa is poor. DRE should not be recommended as a PCa screening test in young men. Furthermore, DRE does not improve the detection of PSA-screen-detected PCa. PATIENT SUMMARY: Our report demonstrated the poor diagnostic performance of digital rectal examination in the screening for prostate cancer in young men.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Krilaviciute A, Becker N, Lakes J, et al. Digital Rectal Examination Is Not a Useful Screening Test for Prostate Cancer. Eur Urol Oncol. 2023. PMID: 37806841. doi:10.1016/j.euo.2023.09.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。